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Objective: To predict the economic consequences of healthcare-acquired-infections arising 
among admissions to Australian acute care hospitals. 
Methods: A quantitative algorithm informed by epidemiological and economic data was 
developed. The setting is all acute care hospitals in Australia and the participants described 
are all admissions to general medical and general surgical specialties. The main outcome 
measures are the numbers of cases of healthcare-acquired-infection and bed days lost 
annually. 
Results: There are a predicted 175,153 (95% Credible Interval 155,911:195,168) cases of 
healthcare-acquired infection among admissions to Australian hospitals annually, and the 
extra stay in hospital to treat symptoms accounts for 854,289 bed days (95% Credible Interval 
645,091:1,096,244). If rates were reduced by 1%, then 150,158 bed days would be released 
for alternative uses. This will allow approximately 38,500 new admissions. 
Conclusions: Healthcare-acquired-infections arising among patients blocks beds in Australian 
hospitals. The cost-effectiveness of hospital services might be improved by allocating more 
resources to infection control, releasing beds and allowing new admissions. 
Implications: There exists an opportunity to improve the efficiency of the Australian health 





Acute hospitals in Australia cannot meet current demand. Waiting lists for elective surgery 
and specialist outpatient appointments are lengthening in every state and territory. In 2004/05 
ninety percent of patients from waiting lists for elective surgery were admitted within 217 
days compared to 197 days for 2002/03 (1). Two forces are at work. The first is that health 
needs are increasing. The emergence of novel and effective therapies alongside a population 
with increasing age and morbidities contribute (2, 3). The second is that healthcare is 
becoming relatively more expensive. Compared to other production processes that comprise a 
modern industrialised economy, healthcare is relatively labour intensive and has been 
described as a ‘handicraft industry’ (4). The result is that every dollar spent on healthcare is 
buying less output as compared to other industries. The costs of supplying healthcare services 
are rising and this partly explains the growth in expenditures among developed countries, 
including Australia (5). 
What remedies are available? The default policy is to leave people on waiting lists, and 
manage demand with queuing. One sensible policy is preventive health strategies such as 
‘quit smoking’ and ‘primary prevention of diabetes’ but these will not completely compensate 
for increasing needs and costs. The supply of hospital bed days could be increased by building 
more hospitals. This is expensive and requires workers to be trained to operate new facilities. 
An alternative is to improve the cost-effectiveness of health services by increasing output for 
the same stock of bed days. This could be achieved by reducing the number of bed days used 
by each patient. There are many reasons why patients stay in hospital and use bed days (6). 
Factors such as age, frailty and underlying illnesses cannot be changed when the patient is 
admitted to hospital. However, the risk of adverse events during the hospital admission that 
increase length of stay - such as falls, pressure ulcers, prescribing errors, cardiac arrests and 
healthcare acquired infection (HAI) - can be reduced by effective intervention. 
Three objectives are addressed by this paper: to estimate the number of cases of HAI and the 
number of bed days lost to HAI for a 12 month period among all Australian hospitals; to 
report these results by site of infection and state/territory; and, to estimate the number of bed 
days that would be gained or lost if there were less or more cases of HAI; this simulates 
changes to the effectiveness of infection control. These objectives are addressed by using a 
quantitative algorithm. It takes a logical structure, is informed with appropriate information 
and uncertainties among parameters are propagated forward to the conclusions. The findings 
can be used to inform decision making about the allocation of resources to infection control 
programmes. 
Method 
The algorithm shown in Figure 1 has two primary outcomes for a 12 month period: the 
number of hospitalised patients with HAI, marked (A); and the number of bed days lost to 
HAI, marked (B). Data are required for three parameters to estimate these outcomes: 
i) the number of patients at risk of HAI 
ii) the incidence rates of HAI 
iii) the extra length of stay associated with HAI.  
The number of cases of HAI (marked A) is estimated from (i) and (ii) and the number of bed 
days lost to HAI for the 12 month period (marked B) is estimated from A and (iii). 
FIGURE 1 HERE 
number of patients at risk of HAI 
Data on hospital activities in 2004-05 by state and territory were obtained from the Australian 
Institute of Health & Welfare (1). The number of admissions to Australian hospitals was 
estimated by adjusting for multiple separations. These data are provided by regional health 
services and represent a census of hospital activity.  
incidence rates of HAI 
Information on the incidence rates for healthcare-acquired urinary tract infection (UTI), lower 
respiratory tract infection (LRTI), blood stream infection (BSI), surgical site infection (SSI), 
‘other’ single sites of infection (OTHER) and cases of patients who acquired more than one 
infection during their admission (MULTI) were obtained from a prospective cohort study 
undertaken in two Australian hospitals in 2002/03 (7-9).  
 extra length of stay associated with HAI 
Estimates of statistical association between HAI and length of stay outcomes in the Australian 
setting are available for healthcare acquired UTI, LRTI and OTHER single sites of infection 
(7), for SSI (8) and for MULTI infection (9). 
evaluation of data 
Beta distributions are fitted to the parameters that describe incidence rates and gamma 
distributions are fitted to the parameters that describe extra length of stay parameters (see 
Appendix 1 for details). Five thousand random samples were taken from the distributions that 
describe the incidence rates and the additional lengths of stay associated with HAI. For each 
re-sample a value for the outcomes ‘number of cases of HAI’ and ‘number of bed days lost to 
HAI’ were calculated and recorded. This process formed a posterior distribution of these 
outcomes and so propagates forward the uncertainties in parameters to conclusion. The 
credible intervals reported contains the true value with a 95% probability. A 95% confidence 
interval contains the true value on 95% of occasions, if the random process could be repeated. 
By definition, a 95% confidence interval misses the true value on 5% of occasions. 95% 
confidence intervals are often interpreted as if they were credible intervals (10). Although a 
95% credible interval is often very similar to a 95% confidence interval, credible intervals are 
far more intuitive to interpret which is why we used them here. Rates of HAI were then 
artificially increased and decreased by 1%, and the algorithm updated, to simulate the effects 
of having more and less infection control. 
Results 
The total number of patients at risk of any HAI in 2004/05, and the number treated in a 
surgical speciality, are summarised in Table 1. 
TABLE 1 HERE 
The incidence rates for HAI among 4,488 admissions to Australian hospitals over 95 days are 
shown in Table 2. 
  TABLE 2 HERE 
There were 228 cases of infection among the 4,488 admissions giving an overall incidence 
rate of 5.08%. The five cases of a single blood stream infection (BSI) shown in Table 2 were 
excluded from this analysis, as no meaningful inference could be drawn from such a small 
number of events.  
No statistical association was found between healthcare-acquired UTI infection and length of 
stay but evidence was found that healthcare-acquired LRTI extended hospital stay by 2.58 
days (95% Confidence Interval 1.80-3.69 days) and OTHER single sites of HAI extended stay 
by 2.61 days  (95% Confidence Interval 2.02-3.39) (7). Evidence was found that healthcare-
acquired SSI infection prolonged length of stay by 2.51 days (95% Confidence Interval 
1.27:4.92) (8) and that more than one HAI (i.e. MULTI) was associated with an increased 
stay of 21 days (95% Confidence Interval 17.3 to 25.1) (9).  
The predicted number of cases of HAI and bed days lost, by state and territory and by site of 
infection, are presented for both the public and private hospital system in Tables 3 and 4. 
TABLES 3 & 4 HERE 
The number of bed days that would be lost to the hospital system if the overall rate increased 
by 1%, and the number of bed days gained from a 1% reduction in rates, are presented in 
Table 5. 
  TABLE 5 HERE 
Discussion 
The algorithm predicts 175,153 (95% Credible Interval 155,911:195,168) cases annually in 
the Australian healthcare system, 63% arise in public hospitals and the remainder in private 
hospitals. Approximately 80% of these cases occur in NSW, Victoria and Queensland and 
UTI is the most common site of infection followed by OTHER, MULTI, LRTI and SSI. Other 
data for the Australian setting suggest that 8.46% of surgical patients first present with a SSI 
after they have left hospital (8). The algorithm predicts 854,289 bed days (95% Credible 
Interval 645,091:1,096,244) are lost annually to HAI. Seventy four percent of these bed days 
are used treating the symptoms of patients who acquired more than one HAI during their 
admission to hospital. If rates increased overall by 1%, then a further 152,336 bed days would 
be lost. If rates are reduced by 1% overall, then 150,158 bed days are released for alternative 
uses. Based on an average length of stay of 3.9 days for admission to public hospitals (11) 
approximately 38,500 new admission could be made with these bed days each year. 
All modelling studies are a simplification of the real world and are characterised by 
uncertainty in their conclusions (12). One limitation of this study is that the parameters were 
informed by data collected from one public tertiary referral hospitals and one public district 
general hospital in south-east Queensland in 2002/2003 (7-9). We are uncertain whether rates 
are stable across states and territories, across the public/private divide or whether rates have 
changed since 2002/03. It is difficult to find other data with which to validate these findings. 
Routinely coded ICD-10 data could be used but they have poor sensitivity and specificity for 
HAI (13). Our method did characterise the variation around the estimates used and so 
uncertainty in the parameters was propagated forward to the conclusions. Repeating data 
collection in each state and territory might not be justified as the findings may not change 
much. A further caveat is that we excluded blood stream infections (BSI) as only 5 cases were 
observed in the primary study (7-9); this number was too small to allow any meaningful 
inference to be drawn about the association between single BSI and length of stay. There were 
a number of BSIs among the patients who has MULTI HAIs (9). BSI is a rare but serious 
problem in Australian hospitals. Data published in 2005 show they occur at a rate of 3.7 per 
1,000 central venous catheter days (14). 
The algorithm used was simple and followed a logical structure. We only included admissions 
to the clinical specialties included in the primary epidemiological study (7-9) (see Appendix 
2), and these account for 52% of all admissions to the public hospital system. We excluded 
patient groups with potentially complex diagnoses and uncertain outcomes, for example: 
transplant, plastic surgery, medical oncology, obstetrics, extensive burns, neonates, 
haematology, chemotherapy, renal medicine, dialysis and neurosurgery. HAI could be a major 
problem in these subgroups but the purpose of our study is to describe the epidemiological 
and economic outcomes for high-volume medical and surgical cases. We also excluded 
patients with a low risk of HAI, for example, patients admitted to: dermatology, diagnostic 
gastrointestinal endoscopy, pain management, dentistry, ophthalmology, tracheostomy, 
perinatology, drug and alcohol, psychiatry, non-acute psychiatry, rehabilitation, palliation and 
psychogeriatric. 
These results are useful for two reasons. The first is to demonstrate the gross costs of HAI. 
The second, and much more useful reason, is to inform economic arguments for programmes 
that reduce rates of HAI. Some interpretation of the costs of HAI is required for both of these 
purposes. We have chosen to use the currency of ‘bed days’ to describe the economic costs of 
HAI. The reason is that most financial expenditures made in the hospital sector are fixed 
within a twelve-month budgeting cycle (15, 16). Preventing infections will not release much 
cash, instead bed days will be released. Assessing the dollar value of the marginal bed-day is 
difficult. Some insight is provided by the facts that Australian policy makers allocated 
resources valued at $14,470 million to supply 14,391 hospital bed days in 2004/05 (1). Based 
on these data, the mean valuation of a bed day is $1,005. By applying this figure to the results 
of this study we see a gross economic burden of HAI of $942,112,531 (95% Credible Interval 
$694,829,471: $1,206,448,693). This number should be interpreted with caution. Policy 
makers appear to value bed days - at current rates of HAI - at $1,005, yet, they might value 
marginal bed days released by expended infection-control differently. As more bed days 
become available from the prevention of HAI, then the valuation may diminish. The real 
economic value depends on the decision makers’ willingness to pay for extra bed days. One 
consideration is that faster throughput will change variable costs and may even increase cost 
associated with infection from MRSA organisms due to increased risk of transmission 
between patients via healthcare workers (17). 
Current infection control activities among Australian hospitals are valuable. We showed a 1% 
increase in rates would lead to an additional loss of 150,158 bed days. In other settings such 
as Argentina, where infection control is less rigorous or even absent, rates of 90 infections per 
1,000 bed days have been shown in the ICU (18). It is not known whether investing additional 
resources for infection control would lead to improved cost-effectiveness among hospitals 
(19, 20), yet methods for economic appraisal in this area have been described (21, 22). 
Indeed, between 10-70% of all HAI can be prevented (23) depending on setting, baseline 
infection rates and type of infection. Research on whether additional infection control in 
Australia is cost-effective should be conducted. High quality modelling studies that synthesise 
evidence from meta-analyses, clinical studies and routine data sources can be used (24). The 
problem of HAI is substantial and a range of interventions can be used to reduce rates and 
improve patient outcomes. There exists potential to improve efficiency in the Australian 










1. Australian Institute of Health & Welfare. Australian Hospital Statistics 2004-05. 
Canberra: Australian Institute of Health & Welfare., 2006. 
2. Mokdad AH, Marks JS, Stroup DF, et al. Actual causes of death in the United States. 
JAMA 2000;291:1238-45. 
3. Murray CJL, Lopez AD. Quantifying the burden of disease and injury attributable to 
ten major risk factors, In. In: Murray CJL, Lopez AD, eds. The Global Burden of 
Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, 
Injuries and Risk Factors in 1990 and Projected to 2020. Boston: Harvard School of 
Public Health on behalf of the World Health Organization and the World Bank, 1996. 
4. Baumol WJ. Health Care as a Handicraft Industry London: Office of Health 
Economics, 1995. 
5. Organisation for Economic Co-operation and Development. The OECD Factbook 
2006. Brussels: OECD, 2006. 
6. Faddy MJ, Graves N, Pettitt A. Modelling length of stay in hospital and other right 
skewed data: comparison of phase-type, gamma and log-normal distributions. Value in 
Health 2008 12:309-14. 
7. Graves  N, Weinhold D, Birrell F, et al. The effect of healthcare-acquired infection on 
length of hospital stay and cost. ICHE 2007;28:280-92. 
8. Graves  N, Halton K, Curtis M, et al. Costs of Surgical Site Infection That Appear 
After Discharge. Emerg Infect Dis 2006;12:831-5. 
9. Graves  N, Clements A, Halton K, et al. Two methods for attributing length of stay to 
healthcare acquired infection. Healthcare Infections 2008;13: 111-9. 
10. O'Hagan A, Luce BR. A primer on BAYESIAN STATISTICS in Health Economics 
and Outcomes Research. University of Sheffield, 2003. 
11. Australian Institute of Health & Welfare. Australian Hospital Statistics 2005-06. 
Canberra: Australian Institute of Health & Welfare., 2007. 
12. Briggs A, Claxton K, Sculpher M. Decision Modelling for Health Economic 
Evaluation. Oxford: Oxford University Press, 2006. 
13. Curtis M, Graves N, Birrell F, et al. A comparison of competing methods for the 
detection of surgical-site infections in patients undergoing total arthroplasty of the 
knee, partial and total arthroplasty of hip and femoral or other vein bypass. Journal of 
Hospital Infection 2004;57:189-93. 
14. McLaws ML, Berry G. Nonuniform risk of bloodstream infection with increasing 
central venous catheter-days. Infect Control Hosp Epidemiol 2005 26:715-9. 
15. Roberts RR, Frutos PW, Ciavarella GC, et al. Distribution of Fixed vs Variable Costs 
of Hospital Care. J Am Med Assoc 1999;281:644-9. 
16. Plowman RP, Graves N, Griffin MAS, et al. The rate and cost of hospital-acquired 
infections occurring in patients admitted to selected specialties of a district general 
hospital in England and the national burden imposed. J Hosp Infect 2001;47:198-209. 
17. Clements A, Halton K, Graves N, et al. Overcrowding and understaffing in modern 
healthcare systems: Key determinants in MRSA transmission. Lancet Infectious 
Diseases 2008;8:427-34. 
18. Rosenthal VD, Guzman S, Orellano PW. Nosocomial infections in medical-surgical 
intensive care units in Argentina: Attributable mortality and length of stay. American 
Journal of Infection Control 2003;31:291-5. 
19. Stone PW, Braccia D, Larson E. Systematic review of economic analyses of health 
care-associated infections. Am J Infect Control 2005;33:501-9. 
20. Stone PW, Larson E, Kawar LN. A systematic audit of economic evidence linking 
nosocomial infections and infection control interventions: 1990-2000. Am J Infect 
Control 2002;30:145-52. 
21. Graves N, Halton K, Lairson D. Economics and preventing hospital-acquired infection 
- Broadening the Perspective. ICHE 2007;28:178-84. 
22. Graves N. Economics and preventing hospital-acquired infection. Emerg Infect Dis 
2004;10:561-6. 
23. Harbarth S, Sax H, Gastmeier P. The preventable proportion of nosocomial infections: 
an overview of published reports. J Hosp Infect 2003;54:258-66. 
24. Claxton K, Sculpher M, Drummond M. A rational framework for decision making by 













Table 1. The total number of patients admitted to Australian hospital in 2004-05 and the number of surgical admissions 
 Patients at risk of any healthcare acquired infection  
Public hospitals    Private Hospitals 
Surgical patients at risk of surgical site healthcare acquired infection  
Public hospitals    Private Hospitals 
NSW 741,784                354,558 365,944                288,812 
VIC 611,721                324,902 305,663                235,175 
QLD 379,744                304,971 193,237                210,433 
WA 184,176                138,288 96,055                  102,676 
SA 188,990                103,737 97,462                   78,262 
Tas 46,148                   0 22,425                    0 
ACT 30,230                   0 16,604                    0 
NT 28,815                   0 13,223                    0 
Total 2,211,608              1,226,456 1,110,613              915,358 
 
Table 2. The number of cases of healthcare acquired infections, denominators and incidence rates for 95 days found in two Australian hospitals.  
 Incidence Rate for 95 days Number of cases At risk population (combined Incidence Rate) 
UTI 1.76% 79 4,488 (4.68%) 
LRTI 0.82% 37 
OTHER 1.09% 49 
MULTI 0.89% 40 
BSI 0.11% 5 
SSI 1.1% 18 1,640 (1.1%) 
Sources (7-9), UTI = healthcare acquired urinary tract infection, LRTI = healthcare acquired lower respiratory tract infection, OTHER = 
healthcare acquired other single site of infection (6 in the digestive system, 2 in the ear, 6 in the mouth and/or oesophagus, 1 in pleural fluid, 10 
at an intravenous catheter insertion site, 18 involving skin, and 6 at an unknown site), MULTI = more than one healthcare acquired infection, BSI 
= healthcare acquired bloodstream infection, SSI = healthcare acquired surgical site infection. Overall Incidence rate of 5.08% arises from: 
228/4488; alternatively, 4.68% + 1.1%*(1640/4,488). 
 
Table 3. The number of cases of HAI, by state and territory and site of infection, 2004/05, and the percentage of cases in public hospitals. 
 UTI (95% CrI) LRTI (95% CrI) OTHER (95% CrI) MULTI (95% CrI) SSI (95% CrI) ALL HAI (95% CrI) 
NSW 18,722 (15,394:22,126), 67% 8,892 (6,541:11,437), 67% 11,719 (9,115:14,645), 67% 9,582 (7,220:12,115), 67% 7,075 (4,607:10,055), 56% 55,989 (49,823:62,412), 66% 
VIC 16,019 (13,171:18,932), 65% 7,608 (5,597:9,785), 65% 10,027 (7,799:12,531), 65% 8,199 (6,178:10,366), 65% 5,850 (3,808:8,313), 56% 47,701 (42,466:53,129), 64% 
QLD 11,683 (9,607:13,808), 55% 5,549 (4,082:7,137), 55% 7,313 (5,689:9,139), 55% 5,980 (4,506:7,561), 55% 4,357 (2,836:6,191), 48% 34,882 (31,049:38,869), 54% 
WA 5,521 (4,540:6,525), 57% 2,622 (1,929:3,373), 57% 3,456 (2,688:4,319), 57% 2,826 (2,129:3,573), 57% 2,151 (1,401:3,057), 48% 16,576 (14,741:18,483), 56% 
SA 4,990 (4,103:5,898), 64% 2,370 (1,744:3,049), 64% 3,124 (2,430:3,904), 64% 2,554 (1,925:3,229), 64% 1,896 (1,235:2,695), 55% 14,934 (13,290:16,650), 63% 
TAS 782 (643:924), 100% 371 (273:478), 100% 489 (381:612), 100% 400 (301:506), 100% 240 (156:341), 100% 2,282 (2,034:2,542), 100% 
ACT  511 (420:604), 100% 243 (179:312), 100% 320 (249:400), 100% 262 (197:331), 100% 177 (115:252), 100% 1,512 (1,346:1,683), 100% 
NT 493 (405:583), 100% 234 (172:301), 100% 309 (240:386), 100% 252 (190:319), 100% 143 (93:203), 100% 1,431 (1,276:1,592), 100% 
Total 58,671 (48,241:69,339), 64% 27,865 (20,499:35,840), 64% 36,724 (28,566:45,895), 64% 30,028 (22,626:37,968), 64% 21,865 (14,236:31,072), 55% 175,153 (155,911:195,168), 63% 
CrI = Credible Interval 
 
 
Table 4. The number of bed days lost to HAI, by state and territory and by site of infection, 2004/05, and the percentage in public hospitals. 
 LRTI (95% CrI) OTHER (95% CrI) MULTI (95% CrI) SSI (95% CrI) ALL HAI (95% CrI) 
NSW 22,761 (8,001:44,052), 67% 30,569 (11,986:57,383), 67% 202,190 (144,868:269,439), 67% 17,324 (4,529:37,243), 56% 272,844 (205,990:350,143), 67% 
VIC 19,475 (6,846:37,692), 65% 26,156 (10,256:49,098), 65% 172,998 (123,952:230,537), 65% 14,323 (3,744:30,791), 56% 232,951 (176,068:299,086), 65% 
QLD 14,204 (4,993:27,491), 55% 19,077 (7,480:35,810), 55% 126,178 (90,406:168,145), 55% 10,667 (2,788:22,933), 48% 170,126 (128,462:218,315), 55% 
WA 6,712 (2,359:12,991), 57% 9,015 (3,535:16,922), 57% 59,625 (42,721:79,456), 57% 5,267 (1,377:11,324), 48% 80,619 (60,791:103,500), 56% 
SA 6,067 (2,133:11,742), 64% 8,148 (3,195:15,296), 64% 53,895 (38,616:71,821), 64% 4,643 (1,214:9,981), 55% 72,753 (54,920:93,359), 64% 
TAS 950 (334:1839), 100% 1,276 (500:2,396), 100% 8,442 (6,049:11,250), 100% 588 (154:1,264), 100% 11,257 (8,511:14,386), 100% 
ACT  621 (218:1202), 100% 834 (327:1566), 100% 5,518 (3,954:7,353), 100% 434 (114:0,933), 100% 7,408 (5,605:9,497), 100% 
NT 599 (211:1160), 100% 805 (316:1511), 100% 5,324 (3,815:7,095), 100% 350 (92:753), 100% 7,079 (5,350:9,049), 100% 
Total 71,328 (25,074:138,051), 64% 95,799 (37,563:179,828), 64% 633,626 (453,991:844,372), 64% 53,536 (13,995:115,092), 55% 854,289 (645,091:1,096,244), 64% 
CrI = Credible Interval 
 
 
Table 5. The change in the number of bed days available to the hospital system from a 1% increase/decrease in overall infection rates 
    LRTI OTHER MULTI SSI ALL HAI 
NSW 1% decrease 4,111 5,230 35,648 3,673 48,661 
1% increase -4,281 -4,931 -36,296 -2,441 -47,949 
VIC 1% decrease 3,517 4,475 30,501 3,036 41,530 
1% increase -3,663 -4,219 -31,056 -2,018 -40,956 
QLD 1% decrease 2,565 3,264 22,246 2,261 30,337 
1% increase -2,672 -3,077 -22,651 -1,503 -29,903 
WA 1% decrease 1,212 1,542 10,512 1,117 14,384 
1% increase -1,262 -1,454 -10,704 -0,742 -14,162 
SA 1% decrease 1,096 1,394 9,502 984 12,976 
1% increase -1,141 -1,314 -9,675 -654 -12,785 
TAS 1% decrease 172 218 1488 125 2003 
1% increase -179 -206 -1516 -83 -1983 
ACT 1% decrease 112 143 973 92 1320 
1% increase -117 -135 -991 -61 -1303 
NT 1% decrease 108 138 939 74 1259 
1% increase -113 -130 -956 -49 -1248 
Total 1% decrease 12,882 16,391 111,714 11,349 152,336 
1% increase -13,416 -15,454 -113,746 -7,542 -150,158 
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Appendix 1. Method used to fit probability distributions 
A beta distribution was fitted for the incidence rates because it is restricted to the interval 0-
1, represents a good fit to the binomial distribution and is continuous. The number of 
patients with an HAI (i.e. events) and the number of patients without an HAI (i.e. non-
events) was used to inform the two non-negative shape parameters, α and β.  
A gamma distribution was fitted for the increase in length of stay due to a diagnosis of HAI. 
The gamma is constrained on the interval 0 to positive infinity and is appropriate for the 
skew found in resource-use data, such as cost and length of stay. The method of moments 
was used to fit this distribution with the expected value and variance of the distribution 
given by, αβ=]0[E  and 2]0var[ αβ= . We set the observed sample mean and variance 
reported in three studies by Graves et al. (7-9) equal to the expressions of the mean and 








Appendix 2. Clinical specialties included in the primary epidemiological study  
Breast endocrine and thoracic, Cardiac surgical unit, Cardiology, Colorectal, 
Diabetes/endocrine, Ear nose and throat, Gastroenterology, General medicine, Geriatric, 
Gynecology, Hepato-pancreato-biliary, Infectious diseases, Intensive care unit, Medical 
stroke unit, Neurology, Orthopedic, Respiratory, Rheumatology, General surgical unit, 
Upper gastrointestine and soft tissue, Urology, Vascular, Women’s and children’s health. 
